263 related articles for article (PubMed ID: 29990547)
21. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
[TBL] [Abstract][Full Text] [Related]
22. Molecular details of INH-C10 binding to wt KatG and Its S315T mutant.
Teixeira VH; Ventura C; Leitão R; Ràfols C; Bosch E; Martins F; Machuqueiro M
Mol Pharm; 2015 Mar; 12(3):898-909. PubMed ID: 25590860
[TBL] [Abstract][Full Text] [Related]
23. Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and Isoniazid susceptibility: an in silico analysis.
Purohit R; Rajendran V; Sethumadhavan R
J Mol Model; 2011 Apr; 17(4):869-77. PubMed ID: 20593210
[TBL] [Abstract][Full Text] [Related]
24. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.
Torres JN; Paul LV; Rodwell TC; Victor TC; Amallraja AM; Elghraoui A; Goodmanson AP; Ramirez-Busby SM; Chawla A; Zadorozhny V; Streicher EM; Sirgel FA; Catanzaro D; Rodrigues C; Gler MT; Crudu V; Catanzaro A; Valafar F
Emerg Microbes Infect; 2015 Jul; 4(7):e42. PubMed ID: 26251830
[TBL] [Abstract][Full Text] [Related]
25. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
[TBL] [Abstract][Full Text] [Related]
26. Modeling the structural origins of drug resistance to isoniazid via key mutations in Mycobacterium tuberculosis catalase-peroxidase, KatG.
Marney MW; Metzger RP; Hecht D; Valafar F
Tuberculosis (Edinb); 2018 Jan; 108():155-162. PubMed ID: 29523317
[TBL] [Abstract][Full Text] [Related]
27. Resonance Raman spectroscopy of Compound II and its decay in Mycobacterium tuberculosis catalase-peroxidase KatG and its isoniazid resistant mutant S315T.
Kapetanaki SM; Chouchane S; Yu S; Magliozzo RS; Schelvis JP
J Inorg Biochem; 2005 Jun; 99(6):1401-6. PubMed ID: 15917090
[TBL] [Abstract][Full Text] [Related]
28. Genetic mechanisms of co-emergence of INH-resistant
Tafess K; Ng TT-L; Tam KK-G; Leung KS-S; Leung JS-L; Lee L-K; Lao HY; Chan CT-M; Yam W-C; Wong SSY; Lau TC-K; Siu GK-H
Microbiol Spectr; 2024 Apr; 12(4):e0213323. PubMed ID: 38466098
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China.
Zhou A; Nawaz M; Duan Y; Moore JE; Millar BC; Xu J; Yao Y
Microb Drug Resist; 2011 Jun; 17(2):275-81. PubMed ID: 21388297
[TBL] [Abstract][Full Text] [Related]
30. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
Unissa AN; Subbian S; Hanna LE; Selvakumar N
Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.
Musser JM; Kapur V; Williams DL; Kreiswirth BN; van Soolingen D; van Embden JD
J Infect Dis; 1996 Jan; 173(1):196-202. PubMed ID: 8537659
[TBL] [Abstract][Full Text] [Related]
32. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.
Vilchèze C; Jacobs WR
Microbiol Spectr; 2014 Aug; 2(4):MGM2-0014-2013. PubMed ID: 26104204
[TBL] [Abstract][Full Text] [Related]
33. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
[TBL] [Abstract][Full Text] [Related]
34. Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis.
Ameeruddin NU; Luke Elizabeth H
Tuberculosis (Edinb); 2014 Dec; 94(6):557-63. PubMed ID: 25270728
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia.
Lavender C; Globan M; Sievers A; Billman-Jacobe H; Fyfe J
Antimicrob Agents Chemother; 2005 Oct; 49(10):4068-74. PubMed ID: 16189082
[TBL] [Abstract][Full Text] [Related]
36. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance.
Rouse DA; DeVito JA; Li Z; Byer H; Morris SL
Mol Microbiol; 1996 Nov; 22(3):583-92. PubMed ID: 8939440
[TBL] [Abstract][Full Text] [Related]
37. [Detection of S315T mutation in the katg gene as a strategy for identification of isoniazid-resistant Mycobacterium tuberculosis in a reference laboratory].
Romay Z; Arráiz N; Fuenmayor A; Ramírez C; Rojas L; París R
Rev Chilena Infectol; 2012 Dec; 29(6):607-13. PubMed ID: 23412028
[TBL] [Abstract][Full Text] [Related]
38. [A simple enzyme test for proving the resistance to isoniazid of Mycobacterium tuberculosis strains].
Homorodean D
Pneumologia; 2005; 54(2):58-61. PubMed ID: 16536002
[TBL] [Abstract][Full Text] [Related]
39. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates].
Yıldırım E; Uzun M
Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061
[TBL] [Abstract][Full Text] [Related]
40. Superoxide reactivity of KatG: insights into isoniazid resistance pathways in TB.
Ghiladi RA; Cabelli DE; Ortiz de Montellano PR
J Am Chem Soc; 2004 Apr; 126(15):4772-3. PubMed ID: 15080669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]